Results 1 to 10 of about 124,599 (285)
Advances in the treatment of invasive fungal disease. [PDF]
PLoS Pathogens, 2023 With over 300 million severe cases and 1.5 million deaths annually, invasive fungal diseases (IFDs) are a major medical burden and source of global morbidity and mortality.
Zhuan Zhang, Gerald F Bills, Zhiqiang An
doaj +4 more sources
Non-invasive diagnosis of invasive fungal disease with cell-free DNA PCR [PDF]
Journal of Clinical MicrobiologyInvasive fungal disease (IFD) is a major cause of morbidity and mortality in the immunocompromised population. Early diagnosis is challenging due to the low sensitivity and non-specificity of non-invasive fungal biomarkers, the need for invasive specimen
Jordan Kit Mah +2 more
doaj +2 more sources
Aspergillus Species Causing Invasive Fungal Disease in Queensland, Australia. [PDF]
Mycopathologia, 2023 Abstract Background Aspergillus species are important causes of invasive fungal disease, particularly among those with an impaired immune system. Increasing reports have revealed a rising incidence of antifungal drug resistance among
Stewart AG +6 more
europepmc +3 more sources
Classifying patients with invasive fungal disease: towards a unified case definition? [PDF]
J Antimicrob ChemotherAbstract Management of invasive fungal disease (IFD) is increasingly challenging due to recognition of novel at-risk groups, emergence of new fungal pathogens and antifungal drug resistance. Together with the availability of new diagnostic tests and treatment modalities, robust and broadly applicable IFD case definitions are critical to ...
Ergün M +10 more
europepmc +4 more sources
Epidemiology of invasive fungal disease in lymphoproliferative disorders
Haematologica, 2015 Invasive fungal disease (IFD) in the immunocompromised host is associated with high mortality,[1][1] prolonged stays in hospital and significant healthcare costs.[2][2] The epidemiology of IFD within the heterogeneous group of patients with lymphoproliferative disorders is not well defined ...
Jasmine C. Teng +7 more
doaj +3 more sources
Pulmonary Invasive Fungal Disease: Ultrasound and Computed Tomography Scan Findings [PDF]
Thoracic Research and Practice, 2023 Seyed Ali Alamdaran +4 more
doaj +2 more sources
Precision Therapy for Invasive Fungal Diseases [PDF]
Journal of Fungi, 2021 Invasive fungal infections (IFI) are a common infection-related cause of death in immunocompromised patients. Approximately 10 million people are at risk of developing invasive aspergillosis annually. Detailed study of the pharmacokinetics (PK) and pharmacodynamics (PD) of antifungal drugs has resulted in a better understanding of optimal regimens for ...
Anne-Grete Märtson +3 more
openaire +4 more sources
Coronavirus Disease 2019–Associated Invasive Fungal Infection [PDF]
Open Forum Infectious Diseases, 2021 Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary invasive fungal infections (IFIs), stemming primarily from severe lung damage and immunologic deficits associated with the virus or immunomodulatory therapy.
John W Baddley +11 more
openaire +3 more sources
Jurnal Penyakit Dalam Indonesia, 2023 Introduction. Invasive fungal infection (IFI) is increasingly common in patients at risk, especially those with impaired immune response. In Indonesia, there is currently a low prevalence of IFI which may be influenced by challenges in diagnosis.
Ariella Alessandro +4 more
doaj +1 more source
Invasive fungal infections in liver diseases
Hepatology Communications, 2023 Patients with liver diseases, including decompensated cirrhosis, alcohol-associated hepatitis, and liver transplant recipients are at increased risk of acquiring invasive fungal infections (IFIs). These infections carry high morbidity and mortality.
Barros, Nicolas +4 more
openaire +3 more sources